EUCTR2012-005243-25-FR进行中（未招募）不适用
Immunogenicity and Safety of the Trivalent Influenza Vaccine (Split-Virion, Inactivated), Northern Hemisphere 2013-2014 Formulation (Intradermal Route)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Aged over 18 years on the day of inclusion
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 65
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 65
排除标准
- •- Subject is pregnant, or lactating, or of childbearing potential
- •- Receipt of any vaccine in the 4 weeks preceding the trial vaccination or
- •planned receipt of any vaccine in the 3 weeks following trial vaccination
- •- Vaccination against flu in the previous 12 months if administered in the
- •context of a clinical trial, or in the previous 6 months if administered in
- •the context of a flu vaccination campaign
研究者
相似试验
进行中（未招募）
1 期
Immunogenicity and Safety of Quadrivalent Influenza Vaccine (VaxigripTetra™) inPregnant WomeEUCTR2016-004763-40-FISanofi Pasteur729
进行中（未招募）
不适用
Safety and Immunogenicity of the Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Children Aged 3 to 8 YearsProphylaxis of influenza in children aged 3 to 8 yearsMedDRA version: 14.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 100000004862EUCTR2011-005374-33-FISanofi Pasteur1,225
进行中（未招募）
不适用
Safety and Immunogenicity of a Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Adult and Elderly SubjectsProphylaxis of influenza in subjects from 18 years of ageMedDRA version: 14.0Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestationsEUCTR2011-001976-21-DESanofi Pasteur1,568
进行中（未招募）
不适用
Safety and Immunogenicity of a Quadrivalent Influenza Vaccine inChild/Adolescent and Adult SubjectsProphylaxis of influenza in subjects from 9-17 years of age (and adults aged 18 to 60 years).MedDRA version: 14.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestationsEUCTR2011-005101-79-Outside-EU/EEASanofi Pasteur2,083
进行中（未招募）
不适用
Study of Sanofi Pasteur's Dengue Vaccine in Healthy Subjects Aged 2 to 45 Years in SingaporePrevention of symptomatic dengue diseaseEUCTR2014-001713-26-Outside-EU/EEASanofi Pasteur SA1,198